Abstract
Periodontitis, one of the most common infectious diseases in humans, is characterized by inflammation of the periodontal tissue and subsequent destruction of the alveolar bone, which ultimately leads to tooth loss. Recently, it was revealed that the osteoclastic bone damage that occurs during periodontitis is dependent on the receptor activator of NF-kB ligand (RANKL) produced by osteoblastic cells and periodontal ligament cells. Immune cells provide essential cues for the RANKL induction that takes place during periodontal inflammation. The knowledge accumulated and experimental tools established in the field of “osteoimmunology” have made crucial contributions to a better understanding of periodontitis pathogenesis and, reciprocally, the investigation of periodontitis has provided important insights into the field. This review discusses the molecular mechanisms underlying periodontal bone loss by focusing on the osteoimmune interactions and RANKL.
Similar content being viewed by others
References
Tsukasaki M, Takayanagi H (2019) Osteoimmunology: evolving concepts in bone-immune interactions in health and disease (in eng). Nat Rev Immunol 19:626–642. https://doi.org/10.1038/s41577-019-0178-8
Tsukasaki M, Komatsu N, Nagashima K, Nitta T, Pluemsakunthai W, Shukunami C, Iwakura Y, Nakashima T, Okamoto K, Takayanagi H (2018) Host defense against oral microbiota by bone-damaging T cells (in eng). Nat Commun 9:701. https://doi.org/10.1038/s41467-018-03147-6
Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis (in eng). Nature 397:315–323. https://doi.org/10.1038/16852
Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, Sawa S, Nitta T, Takayanagi H (2017) Osteoimmunology: the conceptual framework unifying the immune and skeletal systems (in eng). Physiol Rev 97:1295–1349. https://doi.org/10.1152/physrev.00036.2016
Pettit AR, Ji H, von Stechow D, Müller R, Goldring SR, Choi Y, Benoist C, Gravallese EM (2001) TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis (in eng). Am J Pathol 159:1689–1699. https://doi.org/10.1016/S0002-9440(10)63016-7
Tsukasaki M, Hamada K, Okamoto K, Nagashima K, Terashima A, Komatsu N, Win SJ, Okamura T, Nitta T, Yasuda H, Penninger JM, Takayanagi H (2017) LOX fails to substitute for RANKL in osteoclastogenesis (in eng). J Bone Miner Res 32:434–439. https://doi.org/10.1002/jbmr.2990
Tanaka S (2017) RANKL-independent osteoclastogenesis: a long-standing controversy (in eng). J Bone Miner Res 32:431–433. https://doi.org/10.1002/jbmr.3092
Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE (1972) Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes (in eng). Science 177:793–795
Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma (in eng). Nature 408:600–605. https://doi.org/10.1038/35046102
Arron JR, Choi Y (2000) Bone versus immune system (in eng). Nature 408:535–536. https://doi.org/10.1038/35046196
Hajishengallis G (2015) Periodontitis: from microbial immune subversion to systemic inflammation (in eng). Nat Rev Immunol 15:30–44. https://doi.org/10.1038/nri3785
Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA (2011) Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement (in eng). Cell Host Microbe 10:497–506. https://doi.org/10.1016/j.chom.2011.10.006
Maekawa T, Krauss JL, Abe T, Jotwani R, Triantafilou M, Triantafilou K, Hashim A, Hoch S, Curtis MA, Nussbaum G, Lambris JD, Hajishengallis G (2014) Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis (in eng). Cell Host Microbe 15:768–778. https://doi.org/10.1016/j.chom.2014.05.012
Abe T, Hajishengallis G (2013) Optimization of the ligature-induced periodontitis model in mice (in eng). J Immunol Methods 394:49–54. https://doi.org/10.1016/j.jim.2013.05.002
Hajishengallis G, Korostoff JM (2017) Revisiting the page and Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later (in eng). Periodontol 75:116–151. https://doi.org/10.1111/prd.12181
Moutsopoulos NM, Konkel JE (2018) Tissue-specific immunity at the oral mucosal barrier (in eng). Trends Immunol 39:276–287. https://doi.org/10.1016/j.it.2017.08.005
Glowacki AJ, Yoshizawa S, Jhunjhunwala S, Vieira AE, Garlet GP, Sfeir C, Little SR (2013) Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes (in eng). Proc Natl Acad Sci USA 110:18525–18530. https://doi.org/10.1073/pnas.1302829110
Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, Tanaka S, Bluestone JA, Takayanagi H (2014) Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis (in eng). Nat Med 20:62–68. https://doi.org/10.1038/nm.3432
Dutzan N, Kajikawa T, Abusleme L, Greenwell-Wild T, Zuazo CE, Ikeuchi T, Brenchley L, Abe T, Hurabielle C, Martin D, Morell RJ, Freeman AF, Lazarevic V, Trinchieri G, Diaz PI, Holland SM, Belkaid Y, Hajishengallis G, Moutsopoulos NM (2018) A dysbiotic microbiome triggers T (in eng). Sci Transl Med. https://doi.org/10.1126/scitranslmed.aat0797
Okui T, Aoki Y, Ito H, Honda T, Yamazaki K (2012) The presence of IL-17+/FOXP3+ double-positive cells in periodontitis (in eng). J Dent Res 91:574–579. https://doi.org/10.1177/0022034512446341
Rajendran M, Looney S, Singh N, Elashiry M, Meghil MM, El-Awady AR, Tawfik O, Susin C, Arce RM, Cutler CW (2019) Systemic antibiotic therapy reduces circulating inflammatory dendritic cells and Treg-Th17 plasticity in periodontitis (in eng). J Immunol 202:2690–2699. https://doi.org/10.4049/jimmunol.1900046
Kobayashi T, Okada M, Ito S, Kobayashi D, Ishida K, Kojima A, Narita I, Murasawa A, Yoshie H (2014) Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis (in eng). J Periodontol 85:57–67. https://doi.org/10.1902/jop.2013.120696
Moutsopoulos NM, Zerbe CS, Wild T, Dutzan N, Brenchley L, DiPasquale G, Uzel G, Axelrod KC, Lisco A, Notarangelo LD, Hajishengallis G, Holland SM (2017) Interleukin-12 and interleukin-23 blockade in leukocyte adhesion deficiency type 1 (in eng). N Engl J Med 376:1141–1146. https://doi.org/10.1056/NEJMoa1612197
Abe T, AlSarhan M, Benakanakere MR, Maekawa T, Kinane DF, Cancro MP, Korostoff JM, Hajishengallis G (2015) The B cell-stimulatory cytokines BLyS and april are elevated in human periodontitis and are required for B cell-dependent bone loss in experimental murine periodontitis (in eng). J Immunol 195:1427–1435. https://doi.org/10.4049/jimmunol.1500496
Gagliani N, Amezcua Vesely MC, Iseppon A, Brockmann L, Xu H et al (2015) Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation (in eng). Nature 523:221–225. https://doi.org/10.1038/nature14452
Maekawa T, Hosur K, Abe T, Kantarci A, Ziogas A, Wang B, Van Dyke TE, Chavakis T, Hajishengallis G (2015) Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway (in eng). Nat Commun 6:8272. https://doi.org/10.1038/ncomms9272
Kourtzelis I, Li X, Mitroulis I, Grosser D, Kajikawa T et al (2019) DEL-1 promotes macrophage efferocytosis and clearance of inflammation (in eng). Nat Immunol 20:40–49. https://doi.org/10.1038/s41590-018-0249-1
Arizon M, Nudel I, Segev H, Mizraji G, Elnekave M, Furmanov K, Eli-Berchoer L, Clausen BE, Shapira L, Wilensky A, Hovav AH (2012) Langerhans cells down-regulate inflammation-driven alveolar bone loss (in eng). Proc Natl Acad Sci USA 109:7043–7048. https://doi.org/10.1073/pnas.1116770109
Krishnan S, Prise IE, Wemyss K, Schenck LP, Bridgeman HM, McClure FA, Zangerle-Murray T, O’Boyle C, Barbera TA, Mahmood F, Bowdish DME, Zaiss DMW, Grainger JR, Konkel JE (2018) Amphiregulin-producing γδ T cells are vital for safeguarding oral barrier immune homeostasis (in eng). Proc Natl Acad Sci USA 115:10738–10743. https://doi.org/10.1073/pnas.1802320115
Offenbacher S, Jiao Y, Kim SJ, Marchesan J, Moss KL, Jing L, Divaris K, Bencharit S, Agler CS, Morelli T, Zhang S, Sun L, Seaman WT, Cowley D, Barros SP, Beck JD, Munz M, Schaefer AS, North KE (2018) GWAS for Interleukin-1β levels in gingival crevicular fluid identifies IL37 variants in periodontal inflammation (in eng). Nat Commun 9:3686. https://doi.org/10.1038/s41467-018-05940-9
Chen B, Wu W, Sun W, Zhang Q, Yan F, Xiao Y (2014) RANKL expression in periodontal disease: where does RANKL come from? (in eng). Biomed Res Int 2014:731039. https://doi.org/10.1155/2014/731039
Nagasawa T, Kiji M, Yashiro R, Hormdee D, Lu H, Kunze M, Suda T, Koshy G, Kobayashi H, Oda S, Nitta H (2000) Ishikawa I (2007) Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease (in eng). Periodontol 43:65–84. https://doi.org/10.1111/j.1600-0757.2006.00185.x
Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T (1988) Osteoblastic cells are involved in osteoclast formation (in eng). Endocrinology 123:2600–2602. https://doi.org/10.1210/endo-123-5-2600
Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression (in eng). Nat Med 17:1231–1234. https://doi.org/10.1038/nm.2452
Kanzaki H, Chiba M, Shimizu Y, Mitani H (2002) Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis (in eng). J Bone Miner Res 17:210–220. https://doi.org/10.1359/jbmr.2002.17.2.210
Usui M, Sato T, Yamamoto G, Okamatsu Y, Hanatani T, Moritani Y, Sano K, Yamamoto M, Nakashima K (2016) Gingival epithelial cells support osteoclastogenesis by producing receptor activator of nuclear factor kappa B ligand via protein kinase A signaling (in eng). J Periodontal Res 51:462–470. https://doi.org/10.1111/jre.12323
Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, Ernst CW, Izumi Y, Taubman MA (2006) B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease (in eng). Am J Pathol 169:987–998. https://doi.org/10.2353/ajpath.2006.060180
Fujihara R, Usui M, Yamamoto G, Nishii K, Tsukamoto Y, Okamatsu Y, Sato T, Asou Y, Nakashima K, Yamamoto M (2014) Tumor necrosis factor-α enhances RANKL expression in gingival epithelial cells via protein kinase A signaling (in eng). J Periodontal Res 49:508–517. https://doi.org/10.1111/jre.12131
Asano T, Okamoto K, Nakai Y, Tsutsumi M, Muro R, Suematsu A, Hashimoto K, Okamura T, Ehata S, Nitta T, Takayanagi H (2019) Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone vol 1. Nat Metabol 1:868–875
Kanzaki H, Makihira S, Suzuki M, Ishii T, Movila A, Hirschfeld J, Mawardi H, Lin X, Han X, Taubman MA, Kawai T (2016) Soluble RANKL cleaved from activated lymphocytes by TNF-α-converting enzyme contributes to osteoclastogenesis in periodontitis (in eng). J Immunol 197:3871–3883. https://doi.org/10.4049/jimmunol.1601114
Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’Brien CA (2011) Matrix-embedded cells control osteoclast formation (in eng). Nat Med 17:1235–1241. https://doi.org/10.1038/nm.2448
Men Y, Wang Y, Yi Y, Jing D, Luo W, Shen B, Stenberg W, Chai Y, Ge WP, Feng JQ, Zhao H (2020) Gli1+ periodontium stem cells are regulated by osteocytes and occlusal force (in eng). Dev Cell 54:639–54.e6. https://doi.org/10.1016/j.devcel.2020.06.006
Takimoto A, Kawatsu M, Yoshimoto Y, Kawamoto T, Seiryu M, Takano-Yamamoto T, Hiraki Y, Shukunami C (2015) Scleraxis and osterix antagonistically regulate tensile force-responsive remodeling of the periodontal ligament and alveolar bone (in eng). Development 142:787–796. https://doi.org/10.1242/dev.116228
Graves DT, Alshabab A, Albiero ML, Mattos M, Corrêa JD, Chen S, Yang Y (2018) Osteocytes play an important role in experimental periodontitis in healthy and diabetic mice through expression of RANKL (in eng). J Clin Periodontol 45:285–292. https://doi.org/10.1111/jcpe.12851
Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction (in eng). J Exp Med 203:2673–2682. https://doi.org/10.1084/jem.20061775
Lin D, Li L, Sun Y, Wang W, Wang X, Ye Y, Chen X, Xu Y (2014) IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1-JNK/NF-, Äö√¢√†, àö, â†, Äö√Ñ√∂, àö, Ƭ¨¬•B pathways (in eng). Immunology. https://doi.org/10.1111/imm.12395
Yasuhara R, Miyamoto Y, Takami M, Imamura T, Potempa J, Yoshimura K, Kamijo R (2009) Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin (in eng). Biochem J 419:159–166. https://doi.org/10.1042/BJ20081469
Akiyama T, Miyamoto Y, Yoshimura K, Yamada A, Takami M, Suzawa T, Hoshino M, Imamura T, Akiyama C, Yasuhara R, Mishima K, Maruyama T, Kohda C, Tanaka K, Potempa J, Yasuda H, Baba K, Kamijo R (2014) Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain (in eng). J Biol Chem 289:15621–15630. https://doi.org/10.1074/jbc.M113.520510
Ochiai N, Nakachi Y, Yokoo T, Ichihara T, Eriksson T, Yonemoto Y, Kato T, Ogata H, Fujimoto N, Kobayashi Y, Udagawa N, Kaku S, Ueki T, Okazaki Y, Takahashi N, Suda T (2019) Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment (in eng). Commun Biol 2:86. https://doi.org/10.1038/s42003-019-0334-5
Koide M, Kobayashi Y, Ninomiya T, Nakamura M, Yasuda H, Arai Y, Okahashi N, Yoshinari N, Takahashi N, Udagawa N (2013) Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice (in eng). Endocrinology 154:773–782. https://doi.org/10.1210/en.2012-1928
Tsukasaki M, Asano T, Muro R, Huynh NC, Komatsu N, Okamoto K, Nakano K, Okamura T, Nitta T, Takayanagi H (2020) OPG production matters where it happened (in eng). Cell Rep 32:108124. https://doi.org/10.1016/j.celrep.2020.108124
Cawley KM, Bustamante-Gomez NC, Guha AG, MacLeod RS, Xiong J, Gubrij I, Liu Y, Mulkey R, Palmieri M, Thostenson JD, Goellner JJ, O’Brien CA (2020) Local production of osteoprotegerin by osteoblasts suppresses bone resorption (in eng). Cell Rep 32:108052. https://doi.org/10.1016/j.celrep.2020.108052
Oğütcen-Toller M, Tek M, Sener I, Bereket C, Inal S, Ozden B (2010) Intractable bimaxillary osteomyelitis in osteopetrosis: review of the literature and current therapy (in eng). J Oral Maxillofac Surg 68:167–175. https://doi.org/10.1016/j.joms.2005.07.022
Vivier E, van de Pavert SA, Cooper MD, Belz GT (2016) The evolution of innate lymphoid cells (in eng). Nat Immunol 17:790–794. https://doi.org/10.1038/ni.3459
Reisz RR, Scott DM, Pynn BR, Modesto SP (2011) Osteomyelitis in a Paleozoic reptile: ancient evidence for bacterial infection and its evolutionary significance (in eng). Naturwissenschaften 98:551–555. https://doi.org/10.1007/s00114-011-0792-1
Acknowledgements
I thank H.Takayanagi, N.Komatsu, K.Nagashima, T.Nitta, W.Pluemsakunthai, C.Shukunami, Y.Iwakura, T.Nakashima and K.Okamoto for their great contribution to the publications, on which this work is based. This work was supported in part by a grant for the Young Scientists (19K18943) and JSPS fellows (18J00744) from the Japan Society for the Promotion of Science (JSPS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing financial interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tsukasaki, M. RANKL and osteoimmunology in periodontitis. J Bone Miner Metab 39, 82–90 (2021). https://doi.org/10.1007/s00774-020-01165-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-020-01165-3